The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP
Open accessAbstract
Generalized pustular psoriasis (GPP) is a rare disease characterized by recurrent fever and systemic flushing accompanied by extensive sterile pustules. The committee of the guidelines was founded as a collaborative project between the Japanese Dermatological Association and the Study Group for Rare Intractable Skin Diseases under the Ministry of Health, Labour, and Welfare Research Project on Overcoming Intractable Diseases. The aim of the guidelines was to provide current information to aid in the treatment of patients with GPP in Japan. Its contents include the diagnostic and severity classification criteria for GPP, its pathogenesis, and recommendations for the treatment of GPP. Since there are few clinical trial data with high levels of evidence for this rare disease, recommendations by the committee are described in the present guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
Gladman, D. D., Antoni, C., Mease, P., Clegg, D. O., & Nash, P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032482 · Cited by 1,536
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.039 · Cited by 1,222
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Marrakchi, S., Guigue, P., Renshaw, B. R., Puel, A., Pei, X.-Y., Fraitag, S., Zribi, J., Bal, E., Cluzeau, C., Chrabieh, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013068 · Cited by 998
Mease, P. J., Gladman, D. D., Ritchlin, C. T., Ruderman, E. M., Steinfeld, S. D., Choy, E. H. S., Sharp, J. T., Ory, P. A., Perdok, R. J., & Weinberg, M. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21306 · Cited by 909
Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
Mease, P. J., Kivitz, A. J., Burch, F. X., Siegel, E. L., Cohen, S. B., Ory, P., Salonen, D., Rubenstein, J., Sharp, J. T., & Tsuji, W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20335 · Cited by 882
Hyams, J., Crandall, W., Kugathasan, S., Griffiths, A., Olson, A., Johanns, J., Liu, G., Travers, S., Heuschkel, R., Markowitz, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.003 · Cited by 877
McInnes, I. B., Mease, P. J., Kirkham, B., Kavanaugh, A., Ritchlin, C. T., Rahman, P., van der Heijde, D., Landewé, R., Conaghan, P. G., Gottlieb, A. B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61134-5 · Cited by 858
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Gordon, K. B., Blauvelt, A., Papp, K. A., Langley, R. G., Luger, T., Ohtsuki, M., Reich, K., Amato, D., Ball, S. G., Braun, D. K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512711 · Cited by 848
Griffiths, C. E. M., Reich, K., Lebwohl, M., van de Kerkhof, P., Paul, C., Menter, A., Cameron, G. S., Erickson, J., Zhang, L., Secrest, R. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60125-8 · Cited by 834
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Lebwohl, M., Strober, B., Menter, A., Gordon, K., Weglowska, J., Puig, L., Papp, K., Spelman, L., Toth, D., Kerdel, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503824 · Cited by 828
McInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., Brodmerkel, C., Li, S., Wang, Y., Mendelsohn, A. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60594-2 · Cited by 807
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C., Krueger, G. G., de Vlam, K., Birbara, C., Beutler, A., Guzzo, C., Zhou, B., Dooley, L. T., & Kavanaugh, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032268 · Cited by 715
Pathirana, D., Ormerod, A., Saiag, P., Smith, C., Spuls, P., Nast, A., Barker, J., Bos, J., Burmester, G., Chimenti, S., et al. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03389.x · Cited by 703
Salliot, C., & van der Heijde, D. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093690 · Cited by 673
Antoni, C. E., Kavanaugh, A., Kirkham, B., Tutuncu, Z., Burmester, G. R., Schneider, U., Furst, D. E., Molitor, J., Keystone, E., Gladman, D., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20967 · Cited by 640
Gottlieb, A., Menter, A., Mendelsohn, A., Shen, Y.-K., Li, S., Guzzo, C., Fretzin, S., Kunynetz, R., & Kavanaugh, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60140-9 · Cited by 585
Mease, P. J., van der Heijde, D., Ritchlin, C. T., Okada, M., Cuchacovich, R. S., Shuler, C. L., Lin, C.-Y., Braun, D. K., Lee, C. H., & Gladman, D. D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209709 · Cited by 580
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.027 · Cited by 558
Thaçi, D., Blauvelt, A., Reich, K., Tsai, T.-F., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Hugot, S., You, R., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.013 · Cited by 551
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
Onoufriadis, A., Simpson, M. A., Pink, A. E., Di Meglio, P., Smith, C. H., Pullabhatla, V., Knight, J., Spain, S. L., Nestle, F. O., Burden, A. D., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.022 · Cited by 529
Mahadevan, U., Wolf, D. C., Dubinsky, M., Cortot, A., Lee, S. D., Siegel, C. A., Ullman, T., Glover, S., Valentine, J. F., Rubin, D. T., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.011 · Cited by 498
Katz, J. A., Antoni, C., Keenan, G. F., Smith, D. E., Jacobs, S. J., & Lichtenstein, G. R. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30186.x · Cited by 463
Clegg, D. O., Reda, D. J., Mejias, E., Cannon, G. W., Weisman, M. H., Taylor, T., Budiman‐Mak, E., Blackburn, W. D., Vasey, F. B., Mahowald, M. L., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391210 · Cited by 447
Gossec, L., Smolen, J. S., Gaujoux-Viala, C., Ash, Z., Marzo-Ortega, H., van der Heijde, D., FitzGerald, O., Aletaha, D., Balint, P., Boumpas, D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200350 · Cited by 446
PREGNANCY OUTCOME AFTER CYCLOSPORINE THERAPY DURING PREGNANCY: A META-ANALYSIS1
Bar Oz, B., Hackman, R., Einarson, T., & Koren, G. (2001) · Transplantation · doi:10.1097/00007890-200104270-00006 · Cited by 433
Cheent, K., Nolan, J., Shariq, S., Kiho, L., Pal, A., & Arnold, J. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2010.05.001 · Cited by 407
Methotrexate in psoriasis: Consensus conference
Roenigk, H. H., Auerbach, R., Maibach, H., Weinstein, G., & Lebwohl, M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70508-0 · Cited by 393
Etanercept Treatment for Children and Adolescents with Plaque Psoriasis
Paller, A. S., Siegfried, E. C., Langley, R. G., Gottlieb, A. B., Pariser, D., Landells, I., Hebert, A. A., Eichenfield, L. F., Patel, V., Creamer, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa066886 · Cited by 391
Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study
Paul, C. F., HO, V. C., McGeown, C., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12040.x · Cited by 388
Kalb, R. E., Fiorentino, D. F., Lebwohl, M. G., Toole, J., Poulin, Y., Cohen, A. D., Goyal, K., Fakharzadeh, S., Calabro, S., Chevrier, M., et al. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.0718 · Cited by 373
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference
Kalb, R. E., Strober, B., Weinstein, G., & Lebwohl, M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.11.906 · Cited by 368
Incidence and Risk Factors for Psoriasis in the General Population
Huerta, C., Rivero, E., & Rodríguez, L. A. G. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1559 · Cited by 343
Current and future management of psoriasis
Menter, A., & Griffiths, C. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61129-5 · Cited by 321
Blauvelt, A., Reich, K., Tsai, T.-F., Tyring, S., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Vender, R., Hugot, S., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.08.008 · Cited by 312
Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
Hyams, J. S., Griffiths, A., Markowitz, J., Baldassano, R. N., Faubion, W. A., Colletti, R. B., Dubinsky, M., Kierkus, J., Rosh, J., Wang, Y., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.046 · Cited by 311
Opposing roles for calcineurin and ATF3 in squamous skin cancer
Wu, X., Nguyen, B.-C., Dziunycz, P., Chang, S., Brooks, Y., Lefort, K., Hofbauer, G. F. L., & Dotto, G. P. (2010) · Nature · doi:10.1038/nature08996 · Cited by 292
Willkens, R. F., Williams, H. J., Ward, J. R., Egger, M. J., Reading, J. C., Clements, P. J., Cathcart, E. S., Samuelson, C. O., Solsky, M. A., Kaplan, S. B., et al. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270403 · Cited by 289
Smith, C. H., Anstey, A. V., Barker, J. N. W. N., Burden, A. D., Chalmers, R. J. G., Chandler, D., Finlay, A. Y., Grifitths, C. E. M., Jackson, K., McHugh, N. J., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06893.x · Cited by 275
S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update
Nast, A., Boehncke, W., Mrowietz, U., Ockenfels, H., Philipp, S., Reich, K., Rosenbach, T., Sammain, A., Schlaeger, M., Sebastian, M., et al. (2012) · JDDG: Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.07919.x · Cited by 272
Saunte, D. M., Mrowietz, U., Puig, L., & Zachariae, C. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15015 · Cited by 270
Vasiliauskas, E. A., Church, J. A., Silverman, N., Barry, M., Targan, S. R., & Dubinsky, M. C. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.07.018 · Cited by 268
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017
Smith, C. H., Jabbar‐Lopez, Z. K., Yiu, Z. Z., Bale, T., Burden, A. D., Coates, L. C., Cruickshank, M., Hadoke, T., MacMahon, E., Murphy, R., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15665 · Cited by 265
CARTER, J. D., LADHANI, A., RICCA, L. R., VALERIANO, J., & VASEY, F. B. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080545 · Cited by 256
Etanercept and efalizumab for the treatment of psoriasis: a systematic review
Woolacott, N., Hawkins, N., Mason, A., Kainth, A., Khadjesari, Z., Bravo Vergel, Y., Misso, K., Light, K., Chalmers, R., Sculpher, M., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10460 · Cited by 241
A systematic review of treatments for severe psoriasis.
Griffiths, Clark, Chalmers, Po, L. W., & Williams (2000) · Health Technology Assessment · doi:10.3310/hta4400 · Cited by 232
Reich, K., Burden, A. D., Eaton, J. N., & Hawkins, N. S. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10583.x · Cited by 202
Saeki, H., Nakagawa, H., Nakajo, K., Ishii, T., Morisaki, Y., Aoki, T., Cameron, G. S., Osuntokun, O. O., & the Japanese Ixekizumab Study Group (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.13622 · Cited by 195
Reich, K., Pinter, A., Lacour, J. P., Ferrandiz, C., Micali, G., French, L. E., Lomaga, M., Dutronc, Y., Henneges, C., Wilhelm, S., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15666 · Cited by 192
ASAHINA, A., NAKAGAWA, H., ETOH, T., OHTSUKI, M., & THE ADALIMUMAB M04‐688 STUDY GROUP (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00748.x · Cited by 184
The use of cyclosporine in dermatology: Part II
Ryan, C., Amor, K. T., & Menter, A. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.02.062 · Cited by 184
Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases
Emi Aikawa, N., de Carvalho, J. F., Artur Almeida Silva, C., & Bonfá, E. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8140-3 · Cited by 180
Kraan, M. C., van Kuijk, A. W. R., Dinant, H. J., Goedkoop, A. Y., Smeets, T. J. M., de Rie, M. A., Dijkmans, B. A. C., Vaishnaw, A. K., Bos, J. D., & Tak, P. P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10543 · Cited by 167
Mease, P. J., Gladman, D. D., & Keystone, E. C. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21870 · Cited by 158
Weger, W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00702.x · Cited by 156
Ciclosporin in psoriasis clinical practice: an international consensus statement
Griffiths, C. E. M., Dubertret, L., Ellis, C. N., Finlay, A. Y., Finzi, A. F., HO, V. C., Johnston, A. E., Katsambas, A. D., Lison, A.-E., Naeyaert, J. M., et al. (2004) · British Journal of Dermatology · doi:10.1111/j.0366-077x.2004.05949.x · Cited by 152
Nakagawa, H., Niiro, H., & Ootaki, K. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.10.009 · Cited by 147
Gisbert, J. P. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21154 · Cited by 145
Generalized pustular psoriasis (Zumbusch): a French epidemiological survey.
Augey, F., Renaudier, P., & Nicolas, J. (2006) · PubMed · Cited by 144
Sugiura, K. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.02.006 · Cited by 141
Umezawa, Y., Ozawa, A., Kawasima, T., Shimizu, H., Terui, T., Tagami, H., Ikeda, S., Ogawa, H., Kawada, A., Tezuka, T., et al. (2003) · Archives of Dermatological Research · doi:10.1007/s00403-002-0371-6 · Cited by 140
Self-citationSaeki, H., Nakagawa, H., Ishii, T., Morisaki, Y., Aoki, T., Berclaz, P., & Heffernan, M. P. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12773 · Cited by 135
Feldman, S. R., Gordon, K. B., BALA, M. M., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Patel, K. R., Menter, A., & Gottlieb, A. B. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06510.x · Cited by 133
Ikeda, S., Takahashi, H., Suga, Y., Eto, H., Etoh, T., Okuma, K., Takahashi, K., KANBARA, T., Seishima, M., Morita, A., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.09.037 · Cited by 130
Self-citationStrober, B. E., Leonardi, C. L., Papp, K. A., Mrowietz, U., Ohtsuki, M., Bissonnette, R., Ferris, L. K., Paul, C. F., Lebwohl, M., Braun, D. K., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.09.026 · Cited by 130
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
Nast, A., Kopp, I., Augustin, M., Banditt, K., Boehncke, W., Follmann, M., Friedrich, M., Huber, M., Kahl, C. R., Klaus, J., et al. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-007-0744-y · Cited by 129
Measuring quality of life of patients with different clinical types of psoriasis using the SF-36
Sampogna, F., Tabolli, S., Söderfeldt, B., Axtelius, B., Aparo, U. L., & ABENI, D. D. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07071.x · Cited by 128
Rosh, J. R., Lerer, T., Markowitz, J. F., Goli, S. R., Mamula, P., Noe, J. D., Pfefferkorn, M. D., Kelleher, K. T., Griffiths, A. M., Kugathasan, S., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.493 · Cited by 122
Borges‐Costa, J., Silva, R., Gonçalves, L. A. P., Filipe, P., Soares‐de‐Almeida, L., & Gomes, M. M. (2011) · American Journal of Clinical Dermatology · doi:10.2165/11586900-000000000-00000 · Cited by 113
Gottlieb, A. B., Cooper, K. D., McCormick, T. S., Toichi, E., Everitt, D. E., Frederick, B., Zhu, Y., Pendley, C. E., Graham, M. A., & Mascelli, M. A. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x182112 · Cited by 108
Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review
Marchioni, R. M., & Lichtenstein, G. R. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i17.2591 · Cited by 107
Woolacott, N. F., Vergel, Y. B., Hawkins, N., Kainth, A., Khadjesari, Z., Misso, K., Light, K., Asseburg, C., Palmer, S., Claxton, K., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10310 · Cited by 107
Data on the Action Spectrum for Ultraviolet Carcinogenesis2
Freeman, R. G. (1975) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/55.5.1119 · Cited by 106
German S3-guidelines on the treatment of psoriasis vulgaris (short version)
Nast, A., Boehncke, W., Mrowietz, U., Ockenfels, H. M., Philipp, S., Reich, K., Rosenbach, T. O., Sammain, A., Schlaeger, M., Sebastian, M., et al. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1214-8 · Cited by 105
Rustin, M. H. A. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11208.x · Cited by 98
Kavanaugh, A., Antoni, C., Krueger, G. G., Yan, S., BALA, M. M., Dooley, L. T., Beutler, A., Guzzo, C., & Gladman, D. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.040196 · Cited by 96
Ohtsuki, M., Morita, A., Abe, M., Takahashi, H., Seko, N., Karpov, A., Shima, T., Papavassilis, C., Nakagawa, H., & subgroup, T. E. S. J. (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12668 · Cited by 92
Paul, C. F., Gallini, A., Archier, E., Castela, E., Devaux, S., Aractingi, S., Aubin, F., Bachelez, H., Cribier, B. J., Joly, P., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04518.x · Cited by 79
Generalized Pustular Psoriasis Precipitated by Lithium Carbonate
Lowe, N. J. (1978) · Archives of Dermatology · doi:10.1001/archderm.1978.01640240030009 · Cited by 73
Wulf, H. C., Hansen, A. B., & Bech-Thomsen, N. (1994) · PubMed · Cited by 72
Arakawa, A., Ruzicka, T., & Prinz, J. C. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.0751 · Cited by 66
Sugiura, K., Takeichi, T., Kono, M., Ogawa, Y., Shimoyama, Y., Muro, Y., & Akiyama, M. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10953.x · Cited by 64
Self-citationPregnancy outcomes in female renal transplant recipients
Armenti, V. T., McGrory, C. H., Cater, J. R., Radomski, J. S., & Moritz, M. J. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)00408-4 · Cited by 59
Photochemotherapy for pustular psoriasis (von Zumbusch)
Hönigsmann, H., Gschnait, F., Konrad, K., & Wolff, K. (1977) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1977.tb15055.x · Cited by 50
Umezawa, Y., Nakagawa, H., Niiro, H., Ootaki, K., & the Japanese Brodalumab Study Group (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13785 · Cited by 44
Attia, A., Abushouk, A. I., Ahmed, H., Gadelkarim, M., Elgebaly, A. S., Hassan, Z., Abdel‐Daim, M. M., & Negida, A. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0500-9 · Cited by 43
Explaining phenotype heterogeneity in patients with psoriasis
Christophers, E. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08307.x · Cited by 41
The Long-Term Use of Azathioprine in Patients with Psoriatic Arthritis
Lee, J. C. T., Gladman, D. D., Schentag, C. T., & Cook, R. J. (2001) · JCR Journal of Clinical Rheumatology · doi:10.1097/00124743-200106000-00005 · Cited by 38
Blauvelt, A., Papp, K. A., Griffiths, C. E. M., Puig, L., Weisman, J. D., Dutronc, Y., Kerr, L. F., Ilo, D., Mallbris, L., & Augustin, M. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-016-0246-9 · Cited by 38
Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis
Mugheddu, C., Atzori, L., Lappi, A., Pau, M., Murgia, S., & Rongioletti, F. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14234 · Cited by 38
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review.
Woolacott, N. F., Khadjesari, Z., Bruce, I. N., et al. (2007) · PubMed · Cited by 37
The combination of oral acitretin and bath PUVA for the treatment of severe psoriasis
Muchenberger, S., Schöpf, E., & Simon, J. C. (1997) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1997.tb03791.x · Cited by 36
Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis
Ryoo, J. Y., Yang, H., Ji, E., & Yoo, B. K. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028015626545 · Cited by 26
TOKURA, Y. (2011) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01498.x · Cited by 24
Larsen, R., Ryder, L. P., Svejgaard, A., & Gniadecki, R. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03380.x · Cited by 22
Pustular psoriasis and vitiligo in a patient with Turner syndrome
Oiso, N., Ota, T., Kawara, S., & Kawada, A. (2007) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2007.00370.x · Cited by 21
Secukinumab in the Treatment of Generalized Pustular Psoriasis: A Case report
Polesie, S., & Lidholm, A. G. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2467 · Cited by 20
Saeki, H., Watanabe, A., Tada, Y., Kakinuma, T., Komine, M., Ihn, H., Asahina, A., Etoh, T., Kitanaka, S., Sato, U., et al. (2008) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2008.00531.x · Cited by 14
Self-citation
Cited by
Trial of Spesolimab for Generalized Pustular Psoriasis
Bachelez, H., Choon, S.-E., Marrakchi, S., Burden, A. D., Tsai, T.-F., Morita, A., Navarini, A. A., Zheng, M., Xu, J., Turki, H., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2111563 · Cited by 356
Metadata
- Authors
- Fujita, H., Terui, T., Hayama, K., Akiyama, M., Ikeda, S., Mabuchi, T., Ozawa, A., Kanekura, T., Kurosawa, M., Komine, M., Nakajima, K., Sano, S., Nemoto, O., Muto, M., Imai, Y., Yamanishi, K., Aoyama, Y., Iwatsuki, K., & The Japanese Dermatological Association Guidelines Development Committee for the Guidelines for the Management and Treatment of Generalized Pustular Psoriasis
- Venue
- The Journal of Dermatology
- Publisher
- Wiley
- Published
- 2018-09-19
- Volume
- 45
- Issue
- 11
- Pages
- 1235-1270
- ISSN
- 0385-2407 (ISSN-L)
- 1346-8138
- OpenAlex
- W2890431055
- Cited by
- 254
- References
- 101
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.